Status:
COMPLETED
Spectral CT With Advanced CT Technology
Lead Sponsor:
GE Healthcare
Collaborating Sponsors:
Prismatic Sensors AB
Conditions:
CT Photon-Counting
Eligibility:
MALE
50+ years
Phase:
NA
Brief Summary
The purpose of the study is to collect data to evaluate feasibility of the using photon-counting CT in a clinical setting.
Detailed Description
Data collected in this study includes an assessment of image quality parameters including spatial resolution, image contrast, and noise that will evaluate the product and how this photon-counting CT t...
Eligibility Criteria
Inclusion
- Age \>50 years
- Male
- Normal renal function per standardized guidelines (GFR \> 60 mL/min)
- Previous CT examination at KS no more than 12 months prior to the study examination
- Signed informed consent
Exclusion
- Iodine contrast is contraindicated.
Key Trial Info
Start Date :
April 19 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 14 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04781296
Start Date
April 19 2021
End Date
December 14 2022
Last Update
December 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinska University Hospital
Stockholm, Sweden, 17164